Canifelmin Plus XL 100 mg/1000 mg - Tabletten für Hunde
Canifelmin Plus XL 100 mg/1000 mg - Tabletten für Hunde
Not authorised
- Praziquantel
- Fenbendazole
Product identification
Medicine name:
Canifelmin Plus XL 100 mg/1000 mg - Tabletten für Hunde
Active substance:
- Praziquantel
- Fenbendazole
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel100.00/milligram(s)1.00Tablet
-
Fenbendazole1000.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Austria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetviva Richter GmbH
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-00948
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 24/05/2023
Updated on: 4/09/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 6/04/2023
Updated on: 4/09/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 6/04/2023
Updated on: 4/09/2025
at-puar-600000072639-np-caenifelmin-de.pdf
German (PDF)
Download Published on: 25/11/2024
Updated on: 4/09/2025